{"id":20075042,"updated":"2023-07-28T11:04:48Z","additionalIndexing":"08;Vereinte Nationen;Generika;Tropenkrankheit;AIDS;Krankheit;Entwicklungszusammenarbeit;Patent","affairType":{"abbreviation":"Fra.","id":14,"name":"Fragestunde. Frage"},"author":{"councillor":{"code":2624,"gender":"m","id":1134,"name":"Recordon Luc","officialDenomination":"Recordon"},"faction":{"abbreviation":"Fraktion G","code":"G","id":6,"name":"Grüne Fraktion"},"type":"author"},"deposit":{"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2007-03-12T00:00:00Z","legislativePeriod":47,"session":"4716"},"descriptors":[{"key":"L03K100104","name":"Entwicklungszusammenarbeit","type":1},{"key":"L03K010501","name":"Krankheit","type":1},{"key":"L05K1602040202","name":"Patent","type":1},{"key":"L06K010503010201","name":"Generika","type":1},{"key":"L04K01050111","name":"Tropenkrankheit","type":2},{"key":"L04K01050101","name":"AIDS","type":2},{"key":"L02K1504","name":"Vereinte Nationen","type":2}],"drafts":[{"consultation":{"resolutions":[]},"federalCouncilProposal":{},"index":0,"links":[],"preConsultations":[],"references":[],"relatedDepartments":[{"abbreviation":"EDA","id":3,"name":"Departement für auswärtige Angelegenheiten","leading":true}],"states":[{"date":"\/Date(1173654000000+0100)\/","id":229,"name":"Erledigt"}],"texts":[]}],"language":"de","relatedAffairs":[],"roles":[{"councillor":{"code":2624,"gender":"m","id":1134,"name":"Recordon Luc","officialDenomination":"Recordon"},"faction":{"abbreviation":"Fraktion G","code":"G","id":6,"name":"Grüne Fraktion"},"type":"author"}],"shortId":"07.5042","state":{"id":229,"name":"Erledigt","doneKey":"0","newKey":0},"texts":[{"type":{"id":5,"name":"Eingereichter Text"},"value":"<p>Das sechste Uno-Millenniumsziel will bis 2015 die Ausbreitung von Aids (HIV), Malaria, Tuberkulose und andern Armutskrankheiten  mindestens zum Stillstand bringen.<\/p><p>Ist die Schweiz bereit, sich im Rahmen internationaler Vereinbarungen (z. B. WTO) dezidiert dafür einzusetzen, dass die Gesundheit der Menschen Vorrang hat vor dem Patentschutz für pharmazeutische Produkte, insbesondere was die Herstellung und den Vertrieb von Generika betrifft?<\/p>"},{"type":{"id":1,"name":"Titel des Geschäftes"},"value":"Halbzeitbilanz der Uno-Millenniumsziele. MDG 6"}],"title":"Halbzeitbilanz der Uno-Millenniumsziele. MDG 6"}